All lobbying filings

THE CONAFAY GROUP, LLC

THE CONAFAY GROUP, LLC filed a Q3 report for CRESILON, INC. on October 20, 2026, reporting $10,000 in lobbying income.

Lobbying for CRESILON, INC. · Pharmaceutical Company

All filings by THE CONAFAY GROUP, LLC · Everything CRESILON, INC. has reported

Filing · LD-2 quarterly report Q3 report

Reporting period

3rd Quarter 2026

July 1 - Sep 30 · Posted Oct 20, 2026

Income

$10,000

What the client paid this registrant for the period.

Client based in

New York

Official filing document

Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 2

Medical/Disease Research/Clinical Labs

Support for hemostatic technology research and the manufacturing of hemostatic products.

Manufacturing

Support for hemostatic technology research and the manufacturing of hemostatic products.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.